Stay updated on UNCOVER-2: Guselkumab Clinical Trial
Sign up to get notified when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.

Latest updates to the UNCOVER-2: Guselkumab Clinical Trial page
- Check6 days agoChange DetectedA sitewide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision advances from v3.7.1 to v3.7.2, while the study page remains an error page.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the usual ClinicalTrials.gov study details and navigation. This change means the record is currently inaccessible and users cannot view study information or related resources from this page.SummaryDifference18%

- Check41 days agoChange DetectedThe footer revision tag updated from v3.6.6 to v3.7.0, signaling a newer page release. This change reflects a metadata or template update rather than alterations to the study content.SummaryDifference0.0%

- Check55 days agoChange DetectedA new revision tag v3.6.6 was added and the previous v3.6.5 was removed.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5. This indicates a new version of the page was published.SummaryDifference0.0%

Stay in the know with updates to UNCOVER-2: Guselkumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UNCOVER-2: Guselkumab Clinical Trial page.